Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism PIP5K1A inhibitors(phosphatidylinositol-4-phosphate 5-kinase type 1 alpha inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Liver Cancer | Preclinical | India | 01 Feb 2024 |